No. of antibiotics classes | Resistance pattern | No. of isolates | Percentage (%) |
---|---|---|---|
3 | AMI/QNL/CAR | 4 | 1.48 |
 | AMI/TET/QNL | 3 | 1.11 |
 | PEN/AMN/QNL | 2 | 0.74 |
 | PEN/AMN/SUL | 2 | 0.74 |
 | PEN/CEP/QNL | 23 | 8.49 |
 | PEN/PHE/QNL | 8 | 2.95 |
 | PEN/QNL/CAR | 1 | 0.37 |
 | PEN/QNL/SUL | 3 | 1.11 |
 | PEN/TET/QNL | 2 | 0.74 |
 | PHE/QNL/SUL | 2 | 0.74 |
 | TET/CAR/SUL | 3 | 1.11 |
4 | CEP/AMN/QNL/CAR | 3 | 1.11 |
 | CEP/QNL/CAR/SUL | 6 | 2.21 |
 | PEN/AMN/QNL/CAR | 4 | 1.48 |
 | PEN/AMN/QNL/SUL | 2 | 0.74 |
 | PEN/CEP/AMN/QNL | 5 | 1.85 |
 | PEN/CEP/AMN/SUL | 2 | 0.74 |
 | PEN/CEP/PHE/QNL | 2 | 0.74 |
 | PEN/CEP/QNL/CAR | 11 | 4.06 |
 | PEN/CEP/QNL/SUL | 6 | 2.21 |
 | PEN/CEP/TET/SUL | 8 | 2.95 |
 | PEN/QNL/CAR/SUL | 6 | 2.21 |
 | PEN/TET/QNL/CAR | 2 | 0.74 |
 | PEN/TET/QNL/SUL | 21 | 7.75 |
5 | CEP/TET/QNL/CAR/SUL | 4 | 1.48 |
 | PEN/AMN/QNL/CAR/SUL | 2 | 0.74 |
 | PEN/CEP/AMN/QNL/CAR | 7 | 2.58 |
 | PEN/CEP/AMN/TET/QNL | 2 | 0.74 |
 | PEN/CEP/QNL/CAR/SUL | 6 | 2.21 |
 | PEN/CEP/TET/QNL/CAR | 2 | 0.74 |
 | PEN/CEP/TET/QNL/SUL | 38 | 14.02 |
 | PEN/PHE/QNL/CAR/SUL | 2 | 0.74 |
 | PEN/PHE/TET/QNL/CAR | 1 | 0.37 |
 | PEN/PHE/TET/QNL/SUL | 4 | 1.48 |
 | PEN/TET/QNL/CAR/SUL | 2 | 0.74 |
6 | PEN/CEP/AMN/QNL/CAR/SUL | 17 | 6.27 |
 | PEN/CEP/AMN/TET/QNL/CAR | 3 | 1.11 |
 | PEN/CEP/AMN/TET/QNL/SUL | 7 | 2.58 |
 | PEN/CEP/PHE/TET/QNL/SUL | 2 | 0.74 |
 | PEN/CEP/TET/CAR/QNL/SUL | 5 | 1.85 |
 | PEN/CEP/TET/QNL/CAR/SUL | 4 | 1.48 |
 | PEN/PHE/AMN/TET/QNL/SUL | 3 | 1.11 |
7 | PEN/CEP/AMN/TET/QNL/CAR/SUL | 12 | 4.43 |
 | PEN/CEP/PHE/AMN/TET/QNL/CAR | 4 | 1.48 |
 | PEN/CEP/PHE/TET/QNL/CAR/SUL | 7 | 2.58 |
 | PEN/PHE/AMN/TET/QNL/CAR/SUL | 2 | 0.74 |
8 | PEN/CEP/PHE/AMN/TET/QNL/CAR/SUL | 20 | 7.38 |
 |  | 287 | 77.35 |